Summary

Market Overview
The Global Infection Control Apparel Market was valued at USD 17.31 billion in 2024 and is projected to reach USD 22.29 billion by 2030, growing at a CAGR of 4.50%. The COVID-19 pandemic played a pivotal role in accelerating the demand for personal protective equipment (PPE), leading to the widespread adoption of infection control apparel across healthcare and non-healthcare sectors. As infection prevention remains a key concern worldwide, this momentum is expected to sustain future market growth.
Infection control apparel is gaining further traction due to advancements in material science and textile engineering, which are yielding garments with features such as breathability, fluid resistance, and antimicrobial protection—particularly vital in high-risk clinical settings. However, the market continues to face obstacles, especially the high costs tied to manufacturing and procuring advanced protective garments, which can limit adoption in cost-sensitive regions.
Key Market Drivers
Growth in Healthcare Industry
The global healthcare industry’s expansion is a primary force behind the rising demand for infection control apparel. With annual revenues exceeding USD 4 trillion, the industry comprises several major segments, including pharmaceuticals and biotechnology (USD 850 billion) and medical technology and diagnostics (USD 400 billion). As healthcare systems scale up across both developed and developing regions, the volume of clinical activities, surgical procedures, and patient admissions has also surged, leading to increased implementation of infection control measures.
The prevalence of healthcare-associated infections (HAIs) further underlines the critical role of protective apparel. On average, one in ten hospitalized patients contracts an HAI, with rates significantly higher in low- and middle-income countries. Vulnerable populations, such as ICU patients, face even greater risks. In Europe, the overall burden of the six most common HAIs surpasses that of 32 other major infectious diseases combined, reinforcing the necessity for effective infection prevention strategies, including the use of high-quality protective clothing.
Key Market Challenges
Rising Cost of Advanced Materials
The rising cost of high-performance materials used in manufacturing infection control apparel is a significant hurdle in market growth. Products like surgical gowns, gloves, masks, and coveralls now incorporate specialized materials with features such as antimicrobial properties, enhanced fluid resistance, and breathability. These sophisticated fabrics—including multi-layer synthetics and coated nonwovens—are notably more expensive than traditional materials.
With global safety standards becoming more rigorous, manufacturers must invest in materials that meet stringent performance and regulatory criteria. This increase in production cost elevates end-product pricing, posing financial challenges for healthcare systems—especially in regions where budget constraints impact purchasing decisions.
Key Market Trends
Growth of E-Commerce and Digital Distribution Platforms
The expansion of e-commerce and digital distribution platforms is emerging as a transformative trend in the global infection control apparel market. As demand for PPE and infection control garments grows across healthcare and industrial sectors, manufacturers and suppliers are increasingly utilizing digital channels to reach broader customer bases and streamline procurement.
Notably, initiatives such as Toray Industries’ collaboration with the Guinean government underscore the growing role of digital and global outreach in supporting infectious disease prevention. Online portals now allow hospitals and healthcare professionals to place orders more efficiently, track inventory in real-time, and access regulatory documentation—offering significant advantages over traditional supply chains.
Key Market Players
• 3M Company
• DuPont de Nemours, Inc.
• Cardinal Health, Inc.
• Owens & Minor, Inc.
• Medline Industries, Inc.
• Lindström Group
• Ansell Ltd
• Delta Plus Group
• Lakeland Industries Inc.
• Protective Industrial Products, Inc.
Report Scope
In this report, the Global Infection Control Apparel Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Infection Control Apparel Market, By Product:
 o Isolation Gowns
 o Chemotherapy Gowns
 o Lab Coats
 o Jackets
• Infection Control Apparel Market, By End Use:
 o Hospitals
 o Ambulatory & Surgical Centers
 o Clinics
 o Research & Diagnostic Labs
 o Others
• Infection Control Apparel Market, By Region:
 o North America
  § United States
  § Canada
  § Mexico
 o Europe
  § France
  § United Kingdom
  § Italy
  § Germany
  § Spain
 o Asia Pacific
  § China
  § India
  § Japan
  § Australia
  § South Korea
 o South America
  § Brazil
  § Argentina
  § Colombia
 o Middle East & Africa
  § South Africa
  § Saudi Arabia
  § UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Infection Control Apparel Market.
Available Customizations
Global Infection Control Apparel Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Infection Control Apparel Market
5. Global Infection Control Apparel Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets)
5.2.2. By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Infection Control Apparel Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Infection Control Apparel Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By End Use
6.3.2. Mexico Infection Control Apparel Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By End Use
6.3.3. Canada Infection Control Apparel Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By End Use
7. Europe Infection Control Apparel Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Infection Control Apparel Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By End Use
7.3.2. Germany Infection Control Apparel Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By End Use
7.3.3. United Kingdom Infection Control Apparel Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By End Use
7.3.4. Italy Infection Control Apparel Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By End Use
7.3.5. Spain Infection Control Apparel Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By End Use
8. Asia Pacific Infection Control Apparel Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Infection Control Apparel Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By End Use
8.3.2. India Infection Control Apparel Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By End Use
8.3.3. South Korea Infection Control Apparel Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By End Use
8.3.4. Japan Infection Control Apparel Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By End Use
8.3.5. Australia Infection Control Apparel Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By End Use
9. South America Infection Control Apparel Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Infection Control Apparel Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By End Use
9.3.2. Argentina Infection Control Apparel Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By End Use
9.3.3. Colombia Infection Control Apparel Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By End Use
10. Middle East and Africa Infection Control Apparel Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Infection Control Apparel Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Infection Control Apparel Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By End Use
10.3.3. UAE Infection Control Apparel Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers
14. Global Infection Control Apparel Market: SWOT Analysis
15. Porters Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. 3M Company
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. DuPont de Nemours, Inc.
16.3. Cardinal Health, Inc.
16.4. Owens & Minor, Inc.
16.5. Medline Industries, Inc.
16.6. Lindström Group
16.7. Ansell Ltd
16.8. Delta Plus Group
16.9. Lakeland Industries Inc.
16.10. Protective Industrial Products, Inc.
17. Strategic Recommendations
18. About Us & Disclaimer